Work

A targeted phosphoproteomic assay to enable the prediction of response to intensive chemotherapy in acute myeloid leukemia.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.6521

Authors: Gabriel Ghiaur, Josie A. Christopher, Weronika E. Borek, Luis Veiga Nobre, Federico Pedicona, Amy E. Campbell, Janet Kelsall, Olga Ramirez Diaz, Krystyna J. Sykes, David M. Ross, Derek L. Stirewalt, Ian Francis Thomas, Heinz Sill, Brian Huntly, Paolo Gallipoli, Mark D. Minden, John G. Gribben, Arran David Dokal, Edmund H. Wilkes

Institutions: Johns Hopkins University, Johns Hopkins Medicine, South Australia Pathology, Royal Adelaide Hospital, Fred Hutch Cancer Center, Cardiff University, Medical University of Graz, University of Cambridge, Barts Cancer Institute, University Health Network, Princess Margaret Cancer Centre

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Innovate UK

Award: G3207713028

OpenAlex ID: W7162543010

Cites:

Cited by:

Related to: